Univariate and multivariate analyses revealed that MCM2, MCM4, MCM6, MCM7 expression and tumor grade, 1p/19q codeletion, primary therapy outcome, and age were independent factors that influenced the clinical outcome for glioma patients (Table 1). The gene discussed is MCM2; the disease is neoplasm.